Abstract 2139P
Background
Long-term cancer survivors (LS), patients over 5 years free of disease, are a population on the rise due to oncological advances. Our aim is to explore QLACS in long-term cancer survival patients in Spain. As a secondary objective is to study their clinical and sociodemographic characteristics and their preference for social media or face-to-face meetings to obtain oncological information.
Methods
We carried out a transversal study in a sample of LS patients from several Spanish hospitals. They completed QLACS, FERREL, SPF12 and social media data. Different types of tumor were included. Psychometric properties of the QLACS were evaluated. Principal component analysis with Varimax rotation was applied to explore the dimensional structure. Pearson’s correlation (Pc) was used to study associations of QLACS with temporal variables. Student’s t test was used to study differences between them.
Results
N= 257, women=59,9 %, < 65 years=55%. Types Tumor: 33% breast, 27% colorectal, 8,9% urothelial, 7,4% other digestive tumors, 7% orl-lung. Factor analysis showed a 12-component solution accounts for 71.03 % of the variance, showing a similar comparable dimensional structure with QLACS. Alfa Cronbach=0,9. Appearance concern, distress over recurrence, pain, negative feelings and distress familiar are statistically higher in female (p<0,05). We found negative correlation between age and use of social networks for oncological information (Facebook: p = 0.01, Pc: -248; Twitter: p<0.04, Pc:- 200; Instagram: p <0.007, Pc: -259 except; Youtube: p = 0.17; Pc: -134). No differences by sex were observed in the use of social networks There were no differences by age in attending face-to-face meetings: p< 0.94, Pc: - 196. Breast cancer patients are more willing to attend face-to-face meetings to help other patients than those with colon cancer (p< 0.036).
Conclusions
QLACS is a valid and reliable instrument for measuring quality of life in long-term cancer survivors in Spain. Younger patients are more likely to use social media for oncology information. Older people tend to prefer face-to-face meetings. We found differences between men and women in different factors for measuring quality of life.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
M. Cornide.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2141P - Symptom burden and health-related quality of life (HRQoL) in platinum-resistant or -refractory ovarian cancer (PROC): A systematic literature review (SLR)
Presenter: Nikhila Indukuri
Session: Poster session 07
2142P - Criteria for the choice of therapeutic ceiling in the hospitalized oncology patient: Healthcare impact of the multidisciplinary committee with the Intensive Care Unit (ICU)
Presenter: María Esperanza Guirao García
Session: Poster session 07
2143P - Mortality within 30 days after last dose of intravenous systemic anti-cancer therapy: Single-center, one-year, retrospective analysis
Presenter: Osman Sutcuoglu
Session: Poster session 07
2144P - The PRognostic Oncologic Plantology (PROP) website tool predicts 30-day mortality in hospitalized cancer patients on treatment
Presenter: Oriol Mirallas
Session: Poster session 07
2145P - Thromboembolic disease associated with cyclin-dependent kinase inhibitors in patients with breast cancer
Presenter: Javier López Robles
Session: Poster session 07
2146P - Cancer-associated thrombosis clinic: Experience of the Medical Oncology Department of a hospital in Spain
Presenter: Laura Ortega Morán
Session: Poster session 07
2147P - Thrombotic recurrence and bleeding complications in non-small cell lung carcinoma (NSCLC) patients with venous thromboembolism (VTE)
Presenter: Irene Gonzalez Caraballo
Session: Poster session 07
2148P - Venous thromboembolism (VTE) in patients with advanced high grade ovarian carcinoma (aHGOC) receiving PARP inhibitors
Presenter: Lorenzo Gervaso
Session: Poster session 07
2149P - Catheter-related thrombosis in cancer patients: Data from the registry of thrombosis and neoplasia of SEOM (TESEO)
Presenter: Francisco Pelegrín Mateo
Session: Poster session 07
2150P - Clinical and molecular characterisation of cancer-associated venous thromboembolism (VTE)
Presenter: Pau Mascaró Baselga
Session: Poster session 07